

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 7.47700044 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.15182472 |
| 3 | cellular response to interleukin-15 (GO:0071350) | 6.86404504 |
| 4 | negative thymic T cell selection (GO:0045060) | 6.55210402 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.51719168 |
| 6 | negative regulation of cell killing (GO:0031342) | 6.51719168 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.51573501 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.41185960 |
| 9 | response to interleukin-15 (GO:0070672) | 6.30580783 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.08954380 |
| 11 | positive T cell selection (GO:0043368) | 6.08917340 |
| 12 | positive regulation of granulocyte differentiation (GO:0030854) | 5.64599855 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.62965525 |
| 14 | T cell selection (GO:0045058) | 5.61935673 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.59523084 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.50710517 |
| 17 | activated T cell proliferation (GO:0050798) | 5.28806735 |
| 18 | positive thymic T cell selection (GO:0045059) | 5.27612917 |
| 19 | thymic T cell selection (GO:0045061) | 5.17981909 |
| 20 | tolerance induction (GO:0002507) | 5.17154659 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 5.16157952 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.11184700 |
| 23 | regulation of regulatory T cell differentiation (GO:0045589) | 4.95425504 |
| 24 | leukocyte aggregation (GO:0070486) | 4.93555114 |
| 25 | T cell migration (GO:0072678) | 4.80864564 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.71913858 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 4.69721395 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 4.67256350 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.45378269 |
| 30 | negative regulation of phagocytosis (GO:0050765) | 4.37150138 |
| 31 | positive regulation of tolerance induction (GO:0002645) | 4.31781656 |
| 32 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.29552219 |
| 33 | regulation of granulocyte differentiation (GO:0030852) | 4.21626194 |
| 34 | T cell receptor signaling pathway (GO:0050852) | 4.14207167 |
| 35 | positive regulation of isotype switching (GO:0045830) | 4.02372835 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.01908740 |
| 37 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.01471879 |
| 38 | regulation of tolerance induction (GO:0002643) | 3.99296709 |
| 39 | mast cell activation (GO:0045576) | 3.92972661 |
| 40 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.89938225 |
| 41 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.88696344 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.87300666 |
| 43 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.87004808 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.86276574 |
| 45 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.81091321 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.72955676 |
| 47 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.71581585 |
| 48 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.70539750 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.65951893 |
| 50 | positive regulation of B cell differentiation (GO:0045579) | 3.59041869 |
| 51 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.56187712 |
| 52 | detection of bacterium (GO:0016045) | 3.52241651 |
| 53 | positive regulation of interleukin-4 production (GO:0032753) | 3.51788913 |
| 54 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.51376456 |
| 55 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.51376456 |
| 56 | positive regulation of DNA recombination (GO:0045911) | 3.51353933 |
| 57 | interferon-gamma production (GO:0032609) | 3.49666916 |
| 58 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.47903489 |
| 59 | cytidine metabolic process (GO:0046087) | 3.47742652 |
| 60 | cytidine catabolic process (GO:0006216) | 3.47742652 |
| 61 | cytidine deamination (GO:0009972) | 3.47742652 |
| 62 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.45420785 |
| 63 | regulation of activation of Janus kinase activity (GO:0010533) | 3.45241163 |
| 64 | alpha-beta T cell differentiation (GO:0046632) | 3.44326456 |
| 65 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.44277413 |
| 66 | regulation of interleukin-4 production (GO:0032673) | 3.43276574 |
| 67 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.42154691 |
| 68 | regulation of B cell differentiation (GO:0045577) | 3.41253902 |
| 69 | response to interferon-beta (GO:0035456) | 3.40080587 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 3.34707296 |
| 71 | detection of other organism (GO:0098543) | 3.33964889 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.33033075 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.33033075 |
| 74 | response to type I interferon (GO:0034340) | 3.32115829 |
| 75 | regulation of isotype switching (GO:0045191) | 3.31093531 |
| 76 | regulation of defense response to virus by virus (GO:0050690) | 3.30551900 |
| 77 | T cell costimulation (GO:0031295) | 3.27413904 |
| 78 | T cell differentiation (GO:0030217) | 3.25935803 |
| 79 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25253597 |
| 80 | DNA deamination (GO:0045006) | 3.25242339 |
| 81 | lymphocyte costimulation (GO:0031294) | 3.23355721 |
| 82 | T cell homeostasis (GO:0043029) | 3.23225150 |
| 83 | lymphocyte homeostasis (GO:0002260) | 3.20806059 |
| 84 | positive regulation of immunoglobulin production (GO:0002639) | 3.19687065 |
| 85 | alpha-beta T cell activation (GO:0046631) | 3.14511220 |
| 86 | regulation of cell killing (GO:0031341) | 3.13963962 |
| 87 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.12416421 |
| 88 | regulation of natural killer cell differentiation (GO:0032823) | 3.11313147 |
| 89 | signal complex assembly (GO:0007172) | 3.10504538 |
| 90 | positive regulation of cell killing (GO:0031343) | 3.09988095 |
| 91 | mast cell activation involved in immune response (GO:0002279) | 3.09112397 |
| 92 | mast cell degranulation (GO:0043303) | 3.09112397 |
| 93 | lymphocyte migration (GO:0072676) | 3.08467710 |
| 94 | regulation of alpha-beta T cell activation (GO:0046634) | 3.07328706 |
| 95 | positive regulation of B cell mediated immunity (GO:0002714) | 3.04453643 |
| 96 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.04453643 |
| 97 | positive regulation of T cell mediated immunity (GO:0002711) | 3.03878110 |
| 98 | regulation of T cell mediated immunity (GO:0002709) | 3.03620876 |
| 99 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.01312991 |
| 100 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.01214055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.96343971 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.11869180 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.08287824 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.10943385 |
| 5 | MYB_26560356_Chip-Seq_TH2_Human | 4.05840015 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.53126535 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29175463 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.24490512 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.24237498 |
| 10 | MYB_26560356_Chip-Seq_TH1_Human | 3.06641874 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 3.01248073 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99282487 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.99168746 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.87929454 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.86058457 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.80731750 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.70604009 |
| 18 | MAF_26560356_Chip-Seq_TH2_Human | 2.64933103 |
| 19 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.55776747 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.47102684 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.35852734 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 2.24778173 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17744088 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.17376444 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11325017 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11313906 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10612022 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.04781119 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03391107 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96540645 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95955550 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95647748 |
| 33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.93668588 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.90464354 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88103056 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87887796 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72037930 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69620846 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69162570 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.64376613 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.61067529 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59065310 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.58637115 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53598561 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52600926 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50882059 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48129402 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47749085 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.34777353 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33653614 |
| 51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30559731 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29782530 |
| 53 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28048286 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.27188796 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24817670 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23238119 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20770808 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16748342 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15577362 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15372499 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14826008 |
| 62 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12720781 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08984336 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08906341 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08522445 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08067772 |
| 67 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07845563 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06877032 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99991110 |
| 70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99794567 |
| 71 | GATA3_26560356_Chip-Seq_TH1_Human | 0.97800152 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97399350 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93445230 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93110948 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91277021 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87355271 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85874294 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.85193976 |
| 79 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84976708 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84892512 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84817101 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.83967957 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83536881 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82818577 |
| 85 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80703211 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80538465 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80531667 |
| 88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78016127 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77262539 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.77068779 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76614100 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76432842 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75187658 |
| 94 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75097730 |
| 95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.74539933 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73699154 |
| 97 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72728951 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71556040 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.71292583 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70117381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.56361188 |
| 2 | MP0005671_abnormal_response_to | 4.64055383 |
| 3 | MP0001873_stomach_inflammation | 3.59875766 |
| 4 | MP0000685_abnormal_immune_system | 3.56947029 |
| 5 | MP0003436_decreased_susceptibility_to | 3.40481515 |
| 6 | MP0001790_abnormal_immune_system | 3.34060187 |
| 7 | MP0005387_immune_system_phenotype | 3.34060187 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.24173174 |
| 9 | MP0001800_abnormal_humoral_immune | 3.20433543 |
| 10 | MP0008057_abnormal_DNA_replication | 3.08446147 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.88957712 |
| 12 | MP0003724_increased_susceptibility_to | 2.88952934 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.88411824 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.68654794 |
| 15 | MP0001819_abnormal_immune_cell | 2.63901951 |
| 16 | MP0002723_abnormal_immune_serum | 2.60557216 |
| 17 | MP0005025_abnormal_response_to | 2.50661142 |
| 18 | MP0000703_abnormal_thymus_morphology | 2.41424372 |
| 19 | MP0009785_altered_susceptibility_to | 2.36932495 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.34594474 |
| 21 | MP0002398_abnormal_bone_marrow | 2.32547403 |
| 22 | MP0003866_abnormal_defecation | 2.23375635 |
| 23 | MP0004381_abnormal_hair_follicle | 2.22467319 |
| 24 | MP0002405_respiratory_system_inflammati | 2.20428806 |
| 25 | MP0000716_abnormal_immune_system | 2.14860317 |
| 26 | MP0002419_abnormal_innate_immunity | 2.11636428 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.00403324 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.99372862 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.97936761 |
| 30 | MP0004947_skin_inflammation | 1.97802319 |
| 31 | MP0002722_abnormal_immune_system | 1.95023094 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.94373585 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.89017562 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.86100832 |
| 35 | MP0001853_heart_inflammation | 1.85879133 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.84680922 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.79681825 |
| 38 | MP0003303_peritoneal_inflammation | 1.76684244 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.75170019 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.75145273 |
| 41 | MP0002429_abnormal_blood_cell | 1.66883773 |
| 42 | MP0000858_altered_metastatic_potential | 1.60814472 |
| 43 | MP0009278_abnormal_bone_marrow | 1.57911692 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.57628264 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.56732820 |
| 46 | MP0001851_eye_inflammation | 1.55194333 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.46321536 |
| 48 | MP0006082_CNS_inflammation | 1.38790700 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.34144913 |
| 50 | MP0009840_abnormal_foam_cell | 1.28686124 |
| 51 | MP0002933_joint_inflammation | 1.27670388 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.26981147 |
| 53 | MP0002006_tumorigenesis | 1.21977247 |
| 54 | MP0005310_abnormal_salivary_gland | 1.20469687 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.16889632 |
| 56 | MP0002009_preneoplasia | 1.15600658 |
| 57 | MP0001663_abnormal_digestive_system | 1.12165042 |
| 58 | MP0004510_myositis | 1.05795195 |
| 59 | MP0008469_abnormal_protein_level | 1.00132261 |
| 60 | MP0000604_amyloidosis | 0.96216937 |
| 61 | MP0001348_abnormal_lacrimal_gland | 0.96162765 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.95237454 |
| 63 | MP0000490_abnormal_crypts_of | 0.90547577 |
| 64 | MP0003329_amyloid_beta_deposits | 0.88316272 |
| 65 | MP0004130_abnormal_muscle_cell | 0.83254289 |
| 66 | MP0009763_increased_sensitivity_to | 0.81160986 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.81053670 |
| 68 | MP0003448_altered_tumor_morphology | 0.76352334 |
| 69 | MP0002998_abnormal_bone_remodeling | 0.74832048 |
| 70 | MP0005390_skeleton_phenotype | 0.74411516 |
| 71 | MP0009764_decreased_sensitivity_to | 0.71173181 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 0.66252179 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.66252179 |
| 74 | MP0002098_abnormal_vibrissa_morphology | 0.65827891 |
| 75 | MP0002693_abnormal_pancreas_physiology | 0.65791280 |
| 76 | MP0008995_early_reproductive_senescence | 0.65586825 |
| 77 | MP0001919_abnormal_reproductive_system | 0.65545446 |
| 78 | MP0002132_abnormal_respiratory_system | 0.63722612 |
| 79 | MP0003646_muscle_fatigue | 0.63032662 |
| 80 | MP0003786_premature_aging | 0.59552710 |
| 81 | MP0005381_digestive/alimentary_phenotyp | 0.58816467 |
| 82 | MP0003795_abnormal_bone_structure | 0.56315395 |
| 83 | MP0002163_abnormal_gland_morphology | 0.54355358 |
| 84 | MP0004883_abnormal_blood_vessel | 0.53791020 |
| 85 | MP0001765_abnormal_ion_homeostasis | 0.49541609 |
| 86 | MP0001243_abnormal_dermal_layer | 0.47195314 |
| 87 | MP0003045_fibrosis | 0.45418327 |
| 88 | MP0005166_decreased_susceptibility_to | 0.43292880 |
| 89 | MP0004484_altered_response_of | 0.41159364 |
| 90 | MP0000609_abnormal_liver_physiology | 0.41103806 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.39917386 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.39271386 |
| 93 | MP0003091_abnormal_cell_migration | 0.38674305 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.37282943 |
| 95 | MP0004147_increased_porphyrin_level | 0.36781083 |
| 96 | MP0003638_abnormal_response/metabolism_ | 0.35594638 |
| 97 | MP0003880_abnormal_central_pattern | 0.35520781 |
| 98 | MP0004134_abnormal_chest_morphology | 0.34513250 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.33649038 |
| 100 | MP0000249_abnormal_blood_vessel | 0.33483902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 8.36717375 |
| 2 | Stomatitis (HP:0010280) | 7.65080568 |
| 3 | T lymphocytopenia (HP:0005403) | 6.13926732 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.85801926 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.38613863 |
| 6 | Myositis (HP:0100614) | 5.21192644 |
| 7 | Autoimmune hemolytic anemia (HP:0001890) | 5.13582340 |
| 8 | Severe combined immunodeficiency (HP:0004430) | 4.78382157 |
| 9 | Pustule (HP:0200039) | 4.67892258 |
| 10 | IgG deficiency (HP:0004315) | 4.59478349 |
| 11 | Abnormality of T cells (HP:0002843) | 4.50036622 |
| 12 | Increased IgM level (HP:0003496) | 4.27300502 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.88419297 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.86129730 |
| 15 | Combined immunodeficiency (HP:0005387) | 3.85002606 |
| 16 | Abnormality of eosinophils (HP:0001879) | 3.78402895 |
| 17 | Orchitis (HP:0100796) | 3.61607414 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.58628295 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.50416752 |
| 20 | Leukocytosis (HP:0001974) | 3.48473360 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.47584502 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.36613591 |
| 23 | Optic neuritis (HP:0100653) | 3.36613591 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.34224307 |
| 25 | Granulocytopenia (HP:0001913) | 3.26420949 |
| 26 | Eosinophilia (HP:0001880) | 3.22924506 |
| 27 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.15438331 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 3.12881572 |
| 29 | Vasculitis (HP:0002633) | 3.11218900 |
| 30 | Lymphopenia (HP:0001888) | 3.08834523 |
| 31 | Encephalitis (HP:0002383) | 3.07551522 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.06848982 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.06848982 |
| 34 | Meningitis (HP:0001287) | 3.06447819 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 3.03375089 |
| 36 | Increased IgE level (HP:0003212) | 3.03097955 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.02797706 |
| 38 | Recurrent bronchitis (HP:0002837) | 3.01627757 |
| 39 | Hypergammaglobulinemia (HP:0010702) | 2.99701317 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.97392874 |
| 41 | Aplastic anemia (HP:0001915) | 2.93795752 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.90598182 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.89657176 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.86931335 |
| 45 | IgM deficiency (HP:0002850) | 2.86846629 |
| 46 | Episodic fever (HP:0001954) | 2.82575724 |
| 47 | Hypochromic anemia (HP:0001931) | 2.80463119 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 2.79277940 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.75974928 |
| 50 | Obstructive lung disease (HP:0006536) | 2.74994605 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74994605 |
| 52 | Thyroiditis (HP:0100646) | 2.73790903 |
| 53 | Recurrent viral infections (HP:0004429) | 2.72880219 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.70170206 |
| 55 | Stomach cancer (HP:0012126) | 2.68802669 |
| 56 | Recurrent skin infections (HP:0001581) | 2.60559594 |
| 57 | Limb hypertonia (HP:0002509) | 2.56971311 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.54018147 |
| 59 | Hypoplasia of the thymus (HP:0000778) | 2.53851109 |
| 60 | Chronic diarrhea (HP:0002028) | 2.49781249 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46657950 |
| 62 | Chest pain (HP:0100749) | 2.42779459 |
| 63 | Abnormality of the prostate (HP:0008775) | 2.42447786 |
| 64 | Joint swelling (HP:0001386) | 2.40931968 |
| 65 | Petechiae (HP:0000967) | 2.40688340 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.35553824 |
| 67 | Lymphoma (HP:0002665) | 2.29323201 |
| 68 | Anorexia (HP:0002039) | 2.28130206 |
| 69 | Ileus (HP:0002595) | 2.25553488 |
| 70 | Hemoptysis (HP:0002105) | 2.23799984 |
| 71 | Verrucae (HP:0200043) | 2.23779286 |
| 72 | Papilloma (HP:0012740) | 2.23779286 |
| 73 | Urticaria (HP:0001025) | 2.21851839 |
| 74 | Hypochromic microcytic anemia (HP:0004840) | 2.21401274 |
| 75 | Pulmonary embolism (HP:0002204) | 2.21211355 |
| 76 | Prostate neoplasm (HP:0100787) | 2.14080250 |
| 77 | Epistaxis (HP:0000421) | 2.13919655 |
| 78 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.13858022 |
| 79 | Gingivitis (HP:0000230) | 2.11119067 |
| 80 | Basal cell carcinoma (HP:0002671) | 2.10058466 |
| 81 | Microcytic anemia (HP:0001935) | 2.09617554 |
| 82 | Papilledema (HP:0001085) | 2.06320049 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.02335857 |
| 84 | Agammaglobulinemia (HP:0004432) | 2.00104026 |
| 85 | Abnormality of B cell number (HP:0010975) | 1.97581570 |
| 86 | Gangrene (HP:0100758) | 1.97218084 |
| 87 | Bronchitis (HP:0012387) | 1.94672435 |
| 88 | Sepsis (HP:0100806) | 1.90530253 |
| 89 | Hypoproteinemia (HP:0003075) | 1.90431502 |
| 90 | Decreased circulating renin level (HP:0003351) | 1.88502833 |
| 91 | Easy fatigability (HP:0003388) | 1.87948370 |
| 92 | Purpura (HP:0000979) | 1.87272255 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 1.85839673 |
| 94 | Hyperlipoproteinemia (HP:0010980) | 1.81345502 |
| 95 | Hematochezia (HP:0002573) | 1.79202042 |
| 96 | Acute hepatic failure (HP:0006554) | 1.78230500 |
| 97 | Aortic regurgitation (HP:0001659) | 1.74222319 |
| 98 | Hepatosplenomegaly (HP:0001433) | 1.74026596 |
| 99 | Thrombocytosis (HP:0001894) | 1.72951481 |
| 100 | Nasal polyposis (HP:0100582) | 1.71853432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.19260283 |
| 2 | MAP4K1 | 4.87023969 |
| 3 | MUSK | 3.58949741 |
| 4 | SCYL2 | 3.53745791 |
| 5 | BTK | 2.72639175 |
| 6 | ZAP70 | 2.63840461 |
| 7 | NLK | 2.61717500 |
| 8 | ITK | 2.59742418 |
| 9 | GRK6 | 2.46391714 |
| 10 | FES | 2.38218473 |
| 11 | CSK | 2.31952295 |
| 12 | JAK1 | 2.30562126 |
| 13 | SYK | 2.25611058 |
| 14 | TYK2 | 2.09909133 |
| 15 | TEC | 2.04873457 |
| 16 | RIPK4 | 1.97387342 |
| 17 | HCK | 1.90716650 |
| 18 | SIK3 | 1.72509302 |
| 19 | KDR | 1.71933688 |
| 20 | LCK | 1.70267807 |
| 21 | JAK3 | 1.66249938 |
| 22 | PRPF4B | 1.62024842 |
| 23 | VRK2 | 1.50966319 |
| 24 | CAMKK2 | 1.43563169 |
| 25 | IRAK4 | 1.43209452 |
| 26 | FGFR4 | 1.36964030 |
| 27 | TNK2 | 1.36793243 |
| 28 | TAOK3 | 1.27980285 |
| 29 | TESK2 | 1.27875032 |
| 30 | PASK | 1.26074243 |
| 31 | MAP3K14 | 1.24689810 |
| 32 | MAPKAPK3 | 1.22132854 |
| 33 | FGFR3 | 1.22081427 |
| 34 | LYN | 1.17967872 |
| 35 | ERN1 | 1.15056605 |
| 36 | IKBKE | 1.11196903 |
| 37 | MST4 | 1.10923355 |
| 38 | PDK2 | 1.05018966 |
| 39 | CSF1R | 1.02658567 |
| 40 | EPHB1 | 0.99502243 |
| 41 | CAMKK1 | 0.94077062 |
| 42 | TBK1 | 0.93934250 |
| 43 | STK10 | 0.93613442 |
| 44 | CLK1 | 0.92876756 |
| 45 | JAK2 | 0.88572305 |
| 46 | HIPK2 | 0.88355217 |
| 47 | MAP2K3 | 0.85156081 |
| 48 | MARK3 | 0.84824547 |
| 49 | FGR | 0.84810620 |
| 50 | TYRO3 | 0.82300820 |
| 51 | MAP3K11 | 0.77880919 |
| 52 | PIM1 | 0.77590451 |
| 53 | PDK1 | 0.77072479 |
| 54 | PRKCQ | 0.72704622 |
| 55 | BLK | 0.68132603 |
| 56 | IKBKB | 0.66203110 |
| 57 | STK38 | 0.66080557 |
| 58 | EPHA3 | 0.65078162 |
| 59 | MAP3K1 | 0.64023967 |
| 60 | TGFBR2 | 0.61547823 |
| 61 | FYN | 0.60298857 |
| 62 | MAPK12 | 0.59975973 |
| 63 | MAPKAPK2 | 0.56580739 |
| 64 | FGFR2 | 0.55228490 |
| 65 | MAP3K13 | 0.54623563 |
| 66 | CDK19 | 0.54219125 |
| 67 | SIK2 | 0.53650063 |
| 68 | CDK8 | 0.52552940 |
| 69 | PRKCH | 0.51691106 |
| 70 | PDGFRB | 0.50574080 |
| 71 | LRRK2 | 0.49719926 |
| 72 | TESK1 | 0.47751699 |
| 73 | TLK1 | 0.46437105 |
| 74 | MAPK11 | 0.43186116 |
| 75 | KIT | 0.42092522 |
| 76 | TAOK1 | 0.42029319 |
| 77 | MAPK7 | 0.41856473 |
| 78 | MAP3K3 | 0.40873313 |
| 79 | TAOK2 | 0.39038969 |
| 80 | RPS6KA4 | 0.37564666 |
| 81 | GRK7 | 0.35803019 |
| 82 | MAP3K7 | 0.34489852 |
| 83 | CDK12 | 0.32216838 |
| 84 | NEK9 | 0.31843124 |
| 85 | SMG1 | 0.29318939 |
| 86 | CDK4 | 0.27627916 |
| 87 | PTK6 | 0.24179904 |
| 88 | PIK3CG | 0.23980370 |
| 89 | ADRBK2 | 0.23857876 |
| 90 | MAPK13 | 0.23568037 |
| 91 | NTRK2 | 0.23367239 |
| 92 | MAPK3 | 0.23331369 |
| 93 | IGF1R | 0.22730933 |
| 94 | MAPK9 | 0.22303895 |
| 95 | PDPK1 | 0.21642501 |
| 96 | MELK | 0.19976165 |
| 97 | NUAK1 | 0.19086907 |
| 98 | DAPK1 | 0.18432227 |
| 99 | YES1 | 0.17007823 |
| 100 | MAP3K10 | 0.17000033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.52479037 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.16323780 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.50237319 |
| 4 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.73600210 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.73435801 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.58011787 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45967435 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45124652 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.45033916 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31560101 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23092029 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16488186 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.04657323 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94086228 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.90279585 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.74765265 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.65793027 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62024394 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59681876 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59193033 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56375608 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55373280 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53131033 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50445984 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48103135 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42367821 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41749196 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39005981 |
| 29 | HTLV-I infection_Homo sapiens_hsa05166 | 1.30878822 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29086184 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27107715 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.22584830 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21403765 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12632937 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.11563253 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10748995 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10434214 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.09397669 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07343083 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.04895671 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04427437 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00817584 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96747891 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 0.94848208 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92987054 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91476365 |
| 47 | Ribosome_Homo sapiens_hsa03010 | 0.87908414 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.87820486 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86904191 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82000691 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77956026 |
| 52 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75272963 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74453424 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74253983 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73905841 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69380819 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68877428 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68174127 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67280407 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.67020523 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64997996 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63814299 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.63500345 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62205416 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.59764843 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59732718 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.58633068 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56957302 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47073332 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46256937 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45671933 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43561152 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.43252316 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42857194 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41648197 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40713064 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40559727 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40478446 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40320954 |
| 80 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39290446 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.36003051 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35262674 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32777884 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.32646665 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32326623 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30456880 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30071328 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29671355 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29577056 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.27725966 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.27361714 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27010958 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26718567 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25924871 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22670844 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.22135630 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21983547 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.21080297 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20903619 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.18593099 |

